Trial · NCT03784794
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Blood products transfused | 24 hrs | Number of allogeneic blood products transfused intra-op, within 24h after screening and in-hospital (RBC, Platelets and FFP; separate and overall) |
| Secondary | Number of hemocomponents or fibrinogen concentrates needed to treat hypofibrinogenemia | day 0 to day 15 | Number of packs of Cryo (pack of 5 \~ 1 G Fibrinogen), Fibrinogen Concentrate (G), and PCC (500 UI) administered intra-operating |
| Secondary | Incidence of Red Blood Cells transfusion (RBC) | day 0 to day 15 | Incidence ≥ 5 U RBC transfused |
| Secondary | Incidence of Massive Red Blood Cells transfusion (RBC) | day 0 to day 15 | Incidence ≥ 10 U RBC transfused (first 24h after screening) |
| Secondary | estimated blood loss | day 0 to day 15 | Overall estimated blood loss (EBL, ML) |
| Secondary | Time to bleeding control | 24 hrs | time from study entry to last hemostatic intervention/transfusion |
| Secondary | Incidence of coagulopathy | day 0 to day 15 | detected by thromboelastometry or standard coagulation laboratory tests |
| Secondary | Incidence of hysterectomy | day 0 to day 15 | number of obstetric hysterectomy for bleeding control |
| Secondary | Incidence of re-surgery | day 0 to day 15 | number of procedures necessary for bleeding control |
| Secondary | Incidence of Transfused associated circulatory overload | day 0 to day 15 | number of patients with transfused associated circulatory overload |
| Secondary | Incidence of surgical site infection or sepsis | day 0 to day 15 | number of patients that developed health care related infections or sepsis |
| Secondary | Incidence of ICU admission | day 0 to day 15 | number of patients that require admission to the ICU for complications related to hipovolemic shock |
| Secondary | In-hospital mortality | day 0 to day 15 | number of deaths |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03784794/registered